Lactulose efficacy in reduction of nitrogen products, blood potassium and fluid overload in patients with end-stage renal failure
Introduction: Chronic kidney disease (CKD) is a major public health problem that often goes unrecognized until its late-stage. Patients with chronic kidney disease face uremic toxins and hyperkalemia. Also, fluid overload in CKD patients is associated with rapid decline in kidney function. Lactulose...
Saved in:
| Main Authors: | , , |
|---|---|
| Format: | Book |
| Published: |
Islamic Azad University,
2017-06-01T00:00:00Z.
|
| Subjects: | |
| Online Access: | Connect to this object online. |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
MARC
| LEADER | 00000 am a22000003u 4500 | ||
|---|---|---|---|
| 001 | doaj_26363c8aaace4e85b81b14c337fc7a0c | ||
| 042 | |a dc | ||
| 100 | 1 | 0 | |a Negin Aleagha |e author |
| 700 | 1 | 0 | |a Farahnaz Pasha |e author |
| 700 | 1 | 0 | |a Maryam Shiehmorteza |e author |
| 245 | 0 | 0 | |a Lactulose efficacy in reduction of nitrogen products, blood potassium and fluid overload in patients with end-stage renal failure |
| 260 | |b Islamic Azad University, |c 2017-06-01T00:00:00Z. | ||
| 500 | |a 2228-6780 | ||
| 500 | |a 2322-4738 | ||
| 520 | |a Introduction: Chronic kidney disease (CKD) is a major public health problem that often goes unrecognized until its late-stage. Patients with chronic kidney disease face uremic toxins and hyperkalemia. Also, fluid overload in CKD patients is associated with rapid decline in kidney function. Lactulose is a hyperosmotic agent and as a prebiotic, it plays an important role in regulating serum urea and potassium levels and has some effects on fluid overload. The aim of this study was to evaluate the effect of lactulose on serum levels of biochemical products in patients with CKD. Materials and Methods: In this interventional study, 17 patients with end stage of CKD ( 76.47 % men; mean age 65.88 ± 13.4) were evaluated.All patients received lactulose, 10 ml, 3 times per day for 3 months. Blood samples from all participants were collected before and at the end of intervention to examine changes in biochemical parameters, including potassium, urea, creatinine and uric acid. Results: Lactulose significantly decreased urea levels (p=0.001), blood potassium (0.001) and fluid overload(considering the patient's weight p=0.001) in patients with end-stage renal failure. The decrease in serum creatinine and uric acid were not significant. Conclusion: Lactulose administration in CKD patients could decrease levels of various deleterious elements, especially urea and blood potassium and its daily use can be recommended in these patients. | ||
| 546 | |a EN | ||
| 690 | |a Lactulose | ||
| 690 | |a chronic kidney disease | ||
| 690 | |a blood urea | ||
| 690 | |a creatinine | ||
| 690 | |a fluid overload | ||
| 690 | |a Pharmacy and materia medica | ||
| 690 | |a RS1-441 | ||
| 690 | |a Public aspects of medicine | ||
| 690 | |a RA1-1270 | ||
| 655 | 7 | |a article |2 local | |
| 786 | 0 | |n Journal of Pharmaceutical and Health Sciences, Vol 5, Iss 2, Pp 105-109 (2017) | |
| 787 | 0 | |n http://jphs.ir/article_531697.html | |
| 787 | 0 | |n https://doaj.org/toc/2228-6780 | |
| 787 | 0 | |n https://doaj.org/toc/2322-4738 | |
| 856 | 4 | 1 | |u https://doaj.org/article/26363c8aaace4e85b81b14c337fc7a0c |z Connect to this object online. |